Published in JAMA Intern Med on May 27, 2013
Why I will continue to screen prostate-specific antigen for myself and other appropriate men. JAMA Intern Med (2014) 1.06
Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening. BMJ Open (2014) 0.78
Why I will continue to screen prostate-specific antigen for myself and other appropriate men--reply. JAMA Intern Med (2014) 0.75
Involving a Citizens' Jury in Decisions on Individual Screening for Prostate Cancer. PLoS One (2016) 0.75
Prostate-specific antigen testing in france. JAMA Intern Med (2013) 0.75
Who should receive life support during a public health emergency? Using ethical principles to improve allocation decisions. Ann Intern Med (2009) 5.35
Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis (2005) 4.27
Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS (2004) 3.46
Long-term opioid treatment of nonmalignant pain: a believer loses his faith. Arch Intern Med (2010) 2.59
Healthy men should not take statins. JAMA (2012) 2.45
Associations between substance use and sexual risk among very young men who have sex with men. Sex Transm Dis (2006) 2.40
Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One (2008) 2.32
Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA (2007) 2.32
Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2001, USA. Am J Public Health (2002) 2.30
Preventable readmission--is it in the eye of the beholder? JAMA Intern Med (2014) 1.56
Opioids for chronic pain. Arch Intern Med (2011) 1.52
How can we know so little about physician referrals? Arch Intern Med (2012) 1.49
Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis (2002) 1.49
Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis (2007) 1.40
Healthy Young Adults: description and use of an innovative health insurance program. J Adolesc Health (2007) 1.39
Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco. J Acquir Immune Defic Syndr (2002) 1.28
Coping with headaches. JAMA Intern Med (2014) 1.14
Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health (2008) 1.12
The public health response to epidemic syphilis, San Francisco, 1999-2004. Sex Transm Dis (2005) 1.08
Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis (2002) 1.07
Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus. Arch Intern Med (2004) 1.06
Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med (2010) 1.02
Impact of housing on the survival of persons with AIDS. BMC Public Health (2009) 1.01
Simplifying consent increases HIV testing and new case detection: the San Francisco experience. Am J Public Health (2009) 0.99
Is there a proven link between anal cancer screening and reduced morbidity or mortality? Ann Intern Med (2009) 0.98
The effectiveness of patient-delivered partner therapy and chlamydial and gonococcal reinfection in San Francisco. Sex Transm Dis (2010) 0.95
Human immunodeficiency virus is (once again) a primary care disease. Arch Intern Med (2011) 0.90
Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States. AIDS (2004) 0.87
Directing resources to where they are the most needed. JAMA Intern Med (2013) 0.86
Interventions to decrease hospital readmission rates: who saves? Who pays? Arch Intern Med (2011) 0.86
Endemic cryptosporidiosis and exposure to municipal tap water in persons with acquired immunodeficiency syndrome (AIDS): a case-control study. BMC Public Health (2003) 0.86
Clinical decision making during public health emergencies: ethical considerations. Ann Intern Med (2005) 0.85
Mobile tablets: benefits to residents and patients. Arch Intern Med (2012) 0.84
HIV RNA testing in the context of nonoccupational postexposure prophylaxis. J Infect Dis (2004) 0.84
Same-sex domestic partnerships and lower-risk behaviors for STDs, including HIV infection. J Homosex (2006) 0.84
Tobacco-free pharmacies: can we extend the ban? Tob Control (2013) 0.81
Developing methods for less is more. JAMA Intern Med (2014) 0.80
Listeria meningitis after infliximab treatment of ulcerative colitis. J Pediatr Gastroenterol Nutr (2010) 0.80
The San Francisco Community Vital Signs: using web-based tools to facilitate the mobilizing for action through planning and partnerships process. J Public Health Manag Pract (2011) 0.80
Prediction model to maximize impact of syphilis partner notification--San Francisco, 2004-2008. Sex Transm Dis (2010) 0.80
Opioid prescriptions for chronic nonmalignant pain: driving on a dangerous road. JAMA Intern Med (2013) 0.79
A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease. J Clin Pharmacol (2010) 0.79
Creating a medical home in the San Francisco department of public health: establishing patient panels. J Public Health Manag Pract (2009) 0.79
There's no place like home. Arch Intern Med (2011) 0.78
The value of community health workers. Arch Intern Med (2012) 0.78
Reassessing benefits and risks of statins. N Engl J Med (2012) 0.78
Decreasing hospital costs while maintaining quality: can it be done? Arch Intern Med (2010) 0.78
Undertreatment improves, but overtreatment does not. JAMA Intern Med (2013) 0.78
Hope for decreasing socioeconomic disparities. JAMA Intern Med (2015) 0.78
Decreasing use of controlled-release oxycodone: response to Morden et al, June 2008 Medical Care. Med Care (2008) 0.77
Overuse of health care: where are the data? Arch Intern Med (2012) 0.77
Evolving treatment options in coronary artery disease. JAMA Intern Med (2014) 0.77
Writing more specific exercise prescriptions. Arch Intern Med (2012) 0.76
Can Diet Prevent Breast Cancer? JAMA Intern Med (2015) 0.75
Pay for preventing (not causing) health care-associated infections. JAMA Intern Med (2013) 0.75
Serious adverse effects can occur with minor procedures: comment on "Risk of topical anesthetic-induced methemoglobinemia". JAMA Intern Med (2013) 0.75
Scoring a goal [for prevention]. Arch Intern Med (2010) 0.75
Zonisamide: no magic bullet. Arch Intern Med (2012) 0.75
Similar studies with different conclusions: what's a reader to believe? Pain Pract (2011) 0.75
Risks and benefits of medications in real-world practice:. Arch Intern Med (2012) 0.75
Transplanting a kidney is the easy part. JAMA Intern Med (2013) 0.75
Adapting Health Education for the Internet Age. JAMA Intern Med (2016) 0.75
Improving the Health of Persons With Serious Mental Illness. JAMA Intern Med (2015) 0.75
Good prediction rules are hard to find: did we succeed? Arch Intern Med (2012) 0.75
Food surcharges and subsidies: putting your money where your mouth is. Arch Intern Med (2010) 0.75
HIV/AIDS 2010: Better drugs, better technologies, and lingering problems. Arch Intern Med (2010) 0.75
For human immunodeficiency virus disease, more treatment seems to be better: comment on "Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion". Arch Intern Med (2012) 0.75
Live Longer…for Peanuts. JAMA Intern Med (2015) 0.75
Distinguishing Between Substance Use and Substance Use Disorder. JAMA Intern Med (2015) 0.75
Assessment of Drug Use Disorders. JAMA Intern Med (2015) 0.75
Increase screening for hepatitis B among Asians. Arch Intern Med (2012) 0.75
Maintaining planned readmissions. Arch Intern Med (2011) 0.75
We need data on anal screening effectiveness before focusing on increasing it. Am J Public Health (2010) 0.75
No Time to Wait. JAMA Intern Med (2015) 0.75
If only electronic cigarettes were effective smoking cessation devices. JAMA Intern Med (2014) 0.75
Why the cost of fast food matters. JAMA Intern Med (2014) 0.75
Data for a common clinical dilemma. JAMA Intern Med (2014) 0.75
Sun protection for all: but especially for those receiving certain hypertensive medications: comment on "Antihypertensive drugs and lip cancer in non-Hispanic whites". Arch Intern Med (2012) 0.75
Preventing Smoking Relapse After Delivery-Maintaining a Pregnant Pause. JAMA Intern Med (2016) 0.75
How can we know if supplements are safe if we do not know what is in them?: Comment on "The frequency and characteristics of dietary supplement recalls in the United States". JAMA Intern Med (2013) 0.75
Coronary arteries, myocardial infarction, and history. N Engl J Med (2012) 0.75
Bilirubin, gallstones, and mendelian randomization. JAMA Intern Med (2013) 0.75
Valuing our patients' preferences. JAMA Intern Med (2015) 0.75
Hepatitis C treatment: stuck between a rock and a hard place but hoping to be rescued soon. JAMA Intern Med (2014) 0.75
The quitline is calling: comment on "Ask-Advise-Connect". JAMA Intern Med (2013) 0.75
Multiple data sources, the best way to gather safety information about medications. JAMA Intern Med (2014) 0.75
HIV infection among persons born outside the United States. JAMA (2012) 0.75
Harm from long-term opioid therapy: comment on "Long-term analgesic use after low-risk surgery". Arch Intern Med (2012) 0.75
Thinking our way to better treatments of chronic pain. Arch Intern Med (2011) 0.75
Patient satisfaction and safety-net hospitals: carrots, not sticks, are a better approach. Arch Intern Med (2012) 0.75
Mitigating the dangers of opioids. JAMA Intern Med (2015) 0.75
Integrating prediction rules into clinical work flow. JAMA Intern Med (2013) 0.75
Emergency department care: when needed--not when better choices are unavailable. Arch Intern Med (2012) 0.75
Weighing benefits and risks: comment on "Use of glucocorticoids and risk of venous thromboembolism". JAMA Intern Med (2013) 0.75
Time to stop screening for prostate cancer: comment on "Declines in prostate cancer incidence after changes in screening recommendations". Arch Intern Med (2012) 0.75
Quality of residential neighborhood: a modifiable risk factor for type 2 diabetes? Arch Intern Med (2009) 0.75
The right care by the right clinician. JAMA Intern Med (2015) 0.75
Decreasing the Sale of Sugary Beverages: How Sweet It Is. JAMA Intern Med (2017) 0.75
The Supreme Court decision: a victory for uninsured patients. Arch Intern Med (2012) 0.75
A new paradigm for primary care-reply. Arch Intern Med (2012) 0.75